Dr. Gill commented on disasters of Hepatitis with Express News on 28th July 2012.
Dr. Gill commented on disasters of Hepatitis with Express News on 28th July 2012.
Asian Pacific Digestive Week 2012 (APDW 2012) 5-8 December 2012, QSNCC, Bangkok Thailand On behalf of the Scientific Programme Committee, we are pleased to inform you that your abstract A-492-0011-00177 entitled "Treatment Outcomes of Acute Viral Hepatitis C, G 3 Patients with Peg-IFN -Alpha 2b Monotherapy versus Peg-IFN/ Ribavirin Combination" has been accepted for POSTER […]
One in every dozen has it... a very useful note on hepatitis destruction by Dr.Gill
Professor Muzzaffar Gill team will be presenting their research work in United European Gastroenterology conference being held on 20- 24 October 2012, Amsterdam, The Netherland
Article on World Hepatitis Day with Business Times on 28th July 2012
Professor Muzaffar Latif Gill article on daily Jang has provided a useful information of liver diseases.
All over the world, the 19th of May is World Hepatitis Day. This is to make awareness among the people about hepatitis, its spread, prevention and treatment. Following are the comments of Prof. Dr. Muzzaffar Lateef Gill. All over the world, the 19th of May is World Hepatitis Day. This is to make awareness among […]
Professor Gill's team work will be presented in Barcelona , Spain in UEGW (United european gastroenterology week) October 23 to October 27th 2010 UEGW Barcelona 2010 October 23 - 27, 2010 Barcelona/Spain Dear Prof GILL, Thank you for having submitted an abstract for "UEGW 2010" to be held in Barcelona this October. Congratulations! Your […]
Professor Gill's team research Paper "ENTECAVIR AND TENOFOVIR COMBINATION THERAPY IN CHRONIC HEPATITIS B PATIENTS RECEIVED THE BEST STUDY AWARD BY PAKISTAN SOCIETY OF GASTROENTEROLOGY ANNUAL MEETING BEING HELD IN KARACHI ON MARCH 1ST TO MARCH 3RD 2012." ENTECAVIR AND TENOFOVIR COMBINATION THERAPY IN CHRONIC HEPATITIS B PATIENTS RECEIVED THE BEST STUDY AWARD BY PAKISTAN […]
Abstract entitled "OUTCOMES OF ENTECAVIR (ETV) AND TENOFOVIR (TDF) COMBINATION THERAPY IN CHRONIC HEP-B PATIENTS WITH PREVIOUS TREATMENT FAILURE." has been accepted for both ePOSTER and PAPER POSTER PRESENTATION at the International Liver CongressTM 2012 by EASL, taking place in Barcelona, Spain, April 18-22, 2012.
Copyright © 2024 Prof Muzaffar Latif Gill. All rights reserved. Powered By AKITS